These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28875261)

  • 21. Imaging brain microglial activation using positron emission tomography and translocator protein-specific radioligands.
    Owen DR; Matthews PM
    Int Rev Neurobiol; 2011; 101():19-39. PubMed ID: 22050847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of Alzheimer's disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein.
    Ji B; Ono M; Yamasaki T; Fujinaga M; Zhang MR; Seki C; Aoki I; Kito S; Sawada M; Suhara T; Sahara N; Higuchi M
    J Cereb Blood Flow Metab; 2021 Aug; 41(8):2076-2089. PubMed ID: 33557690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generalization of endothelial modelling of TSPO PET imaging: Considerations on tracer affinities.
    Rizzo G; Veronese M; Tonietto M; Bodini B; Stankoff B; Wimberley C; Lavisse S; Bottlaender M; Bloomfield PS; Howes O; Zanotti-Fregonara P; Turkheimer FE; Bertoldo A
    J Cereb Blood Flow Metab; 2019 May; 39(5):874-885. PubMed ID: 29135382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promising potential of new generation translocator protein tracers providing enhanced contrast of arthritis imaging by positron emission tomography in a rat model of arthritis.
    Gent YY; Weijers K; Molthoff CF; Windhorst AD; Huisman MC; Kassiou M; Jansen G; Lammertsma AA; van der Laken CJ
    Arthritis Res Ther; 2014 Mar; 16(2):R70. PubMed ID: 24625077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic analysis of the translocator protein positron emission tomography ligand [
    Feeney C; Scott G; Raffel J; Roberts S; Coello C; Jolly A; Searle G; Goldstone AP; Brooks DJ; Nicholas RS; Trigg W; Gunn RN; Sharp DJ
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2201-2210. PubMed ID: 27349244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation.
    Owen DR; Howell OW; Tang SP; Wells LA; Bennacef I; Bergstrom M; Gunn RN; Rabiner EA; Wilkins MR; Reynolds R; Matthews PM; Parker CA
    J Cereb Blood Flow Metab; 2010 Sep; 30(9):1608-18. PubMed ID: 20424634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis.
    Nutma E; Stephenson JA; Gorter RP; de Bruin J; Boucherie DM; Donat CK; Breur M; van der Valk P; Matthews PM; Owen DR; Amor S
    Brain; 2019 Nov; 142(11):3440-3455. PubMed ID: 31578541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging the Influence of Red Blood Cell Docosahexaenoic Acid Status on the Expression of the 18 kDa Translocator Protein in the Brain: A [
    Tollefson S; Himes ML; Kozinski KM; Lopresti BJ; Mason NS; Hibbeln J; Muldoon MF; Narendran R
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Oct; 7(10):998-1006. PubMed ID: 34607054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [
    Sridharan S; Raffel J; Nandoskar A; Record C; Brooks DJ; Owen D; Sharp D; Muraro PA; Gunn R; Nicholas R
    Mol Imaging Biol; 2019 Oct; 21(5):935-944. PubMed ID: 30796709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can Studies of Neuroinflammation in a TSPO Genetic Subgroup (HAB or MAB) Be Applied to the Entire AD Cohort?
    Fan Z; Harold D; Pasqualetti G; Williams J; Brooks DJ; Edison P
    J Nucl Med; 2015 May; 56(5):707-13. PubMed ID: 25840980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
    Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
    J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of Macrophage-Driven Inflammation During Myocardial Infarction with
    MacAskill MG; Stadulyte A; Williams L; Morgan TEF; Sloan NL; Alcaide-Corral CJ; Walton T; Wimberley C; McKenzie CA; Spath N; Mungall W; BouHaidar R; Dweck MR; Gray GA; Newby DE; Lucatelli C; Sutherland A; Pimlott SL; Tavares AAS
    J Nucl Med; 2021 Apr; 62(4):536-544. PubMed ID: 32859708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The methodology of TSPO imaging with positron emission tomography.
    Turkheimer FE; Rizzo G; Bloomfield PS; Howes O; Zanotti-Fregonara P; Bertoldo A; Veronese M
    Biochem Soc Trans; 2015 Aug; 43(4):586-92. PubMed ID: 26551697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiolabelled molecules for imaging the translocator protein (18 kDa) using positron emission tomography.
    Dollé F; Luus C; Reynolds A; Kassiou M
    Curr Med Chem; 2009; 16(22):2899-923. PubMed ID: 19689272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects.
    Varrone A; Oikonen V; Forsberg A; Joutsa J; Takano A; Solin O; Haaparanta-Solin M; Nag S; Nakao R; Al-Tawil N; Wells LA; Rabiner EA; Valencia R; Schultze-Mosgau M; Thiele A; Vollmer S; Dyrks T; Lehmann L; Heinrich T; Hoffmann A; Nordberg A; Halldin C; Rinne JO
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):438-46. PubMed ID: 25412766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [¹¹C]PBR28 PET study.
    Hannestad J; DellaGioia N; Gallezot JD; Lim K; Nabulsi N; Esterlis I; Pittman B; Lee JY; O'Connor KC; Pelletier D; Carson RE
    Brain Behav Immun; 2013 Oct; 33():131-8. PubMed ID: 23850810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TSPO polymorphism in individuals with alcohol use disorder: Association with cholesterol levels and withdrawal severity.
    Wiers CE; Martins De Carvalho L; Hodgkinson CA; Schwandt M; Kim SW; Diazgranados N; Wang GJ; Goldman D; Volkow ND
    Addict Biol; 2021 Jan; 26(1):e12838. PubMed ID: 31713961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of simplified methods for quantification of [
    Van Camp N; Balbastre Y; Herard AS; Lavisse S; Tauber C; Wimberley C; Guillermier M; Berniard A; Gipchtein P; Jan C; Badin RA; Delzescaux T; Hantraye P; Bonvento G
    J Cereb Blood Flow Metab; 2020 May; 40(5):1103-1116. PubMed ID: 31238764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PET imaging of [
    Varnäs K; Cselényi Z; Jucaite A; Halldin C; Svenningsson P; Farde L; Varrone A
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):367-375. PubMed ID: 30270409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [18F]FEBMP: Positron Emission Tomography Imaging of TSPO in a Model of Neuroinflammation in Rats, and in vitro Autoradiograms of the Human Brain.
    Tiwari AK; Ji B; Yui J; Fujinaga M; Yamasaki T; Xie L; Luo R; Shimoda Y; Kumata K; Zhang Y; Hatori A; Maeda J; Higuchi M; Wang F; Zhang MR
    Theranostics; 2015; 5(9):961-9. PubMed ID: 26155312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.